Baijin Life Science Holdings (HKSE:01466) Change In Receivables : HK$-17.81 Mil (TTM As of Sep. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Baijin Life Science Holdings Change In Receivables?

Baijin Life Science Holdings's change in receivables for the quarter that ended in Sep. 2024 was HK$-15.68 Mil. It means Baijin Life Science Holdings's Accounts Receivable increased by HK$15.68 Mil from Mar. 2024 to Sep. 2024 .

Baijin Life Science Holdings's change in receivables for the fiscal year that ended in Mar. 2024 was HK$-2.23 Mil. It means Baijin Life Science Holdings's Accounts Receivable increased by HK$2.23 Mil from Mar. 2023 to Mar. 2024 .

Baijin Life Science Holdings's Accounts Receivable for the quarter that ended in Sep. 2024 was HK$26.39 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Baijin Life Science Holdings's Days Sales Outstanding for the six months ended in Sep. 2024 was 67.93.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Baijin Life Science Holdings's liquidation value for the six months ended in Sep. 2024 was HK$-40.68 Mil.

Baijin Life Science Holdings Change In Receivables Historical Data

The historical data trend for Baijin Life Science Holdings's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Baijin Life Science Holdings Change In Receivables Chart

Baijin Life Science Holdings Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Change In Receivables

Get a 7-Day Free Trial

5.95

14.91

3.04

3.67

-2.23

Baijin Life Science Holdings Semi-Annual Data
	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
Change In Receivables	Get a 7-Day Free Trial															3.92	-0.25	-0.10	-2.13	-15.68

Baijin Life Science Holdings Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-17.81 Mil.

Baijin Life Science Holdings (HKSE:01466) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Baijin Life Science Holdings's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	26.392	/	70.9	*	91
=	67.93

2. In Ben Graham's calculation of liquidation value, Baijin Life Science Holdings's accounts receivable are only considered to be worth 75% of book value:

Baijin Life Science Holdings's liquidation value for the quarter that ended in Sep. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	44.37	-	129.259	+	0.75 * 26.392	+	0.5 * 48.825
=	-40.68

Baijin Life Science Holdings Change In Receivables Related Terms

Thank you for viewing the detailed overview of Baijin Life Science Holdings's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Baijin Life Science Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Retail - Cyclical » Baijin Life Science Holdings Ltd (HKSE:01466) » Definitions » Change In Receivables

Traded in Other Exchanges

MNNGF:USA

Address

66 Gloucester Road, Office B, 9/F Pico Tower, Wanchai, Hong Kong, HKG

Website

http://www.affluent-partners.com

Baijin Life Science Holdings Ltd is positioned as a biopharmaceutical company dedicated in anti-aging and preventive medicine, as well as cellular precision therapy. The company produces health products that are affordable for the general public. The business segments of the company are Life Science segment which includes cellular technology-based services, provide including cellular drugs R&D, large molecule drugs R&D, clinical research services and R&D and sales on self-owned skincare brand, and Fine Jewelry segment that focuses on the procurement, processing, design, production and wholesale distribution of pearls and fine jewelry products.

Executives

Pacific Wish Limited
Chan Vincent Wing Sing
Hui Ka Man Emily
Ketto Inform Limited	2101 Beneficial owner
Su Yaoyao	2201 Interest of corporation controlled by you

Baijin Life Science Holdings Headlines

No Headlines